explore -WSS

explore

author：hotspot 2025-10-02 19:19:37 - browse：1211

Traffic on the Longfellow Bridge and the Kendall Square skyline are seen. -- health coverage from STAT — Michael Dwyer/AP

Around this time three years ago, while most of us navigated pandemic life, real estate developers across Greater Boston looked to life-science laboratories, and saw dollar signs.

The white-collar office workers who’d long filled downtown towers were largely staying home (unless they worked in commercial real estate). The future of cities had rarely been murkier.

But many biotech companies, like Cambridge’s Moderna, were busier than ever, and growing fast. Life-science companies, and the lab buildings that house them, looked like a sure bet for investors. Money poured in to drug companies by the billions — from venture capitalists, the stock market, the National Institutes of Health. And big real estate investors followed, launching a wave of speculative lab development all over Greater Boston.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： To bolster infectious disease surveillance, genomics powerhouses team up

explore

leisure time

WSS

Dog Aging Project founders on what lies ahead after losing funding

Truvian presents data for its desktop blood

Maisha Meds is a PBM, but don't call it that

New lawsuit accuses health insurer Cigna of denying claims in bulk

Inaction leaves children at risk from dangerous chemotherapy drug

The haunting brain science of long Covid

hotspot

explore

entertainment

Guidelines to prevent youth baseball injuries need more muscle

FDA endorses new sterilization method for medical devices

In Memoriam: Notable people who died in 2023

FDA endorses new sterilization method for medical devices

DIEP, the 'gold standard' of breast reconstruction, is under threat

Rise in cancer among younger people worries and puzzles doctors

Continuity nursing helped my family in our darkest PICU moments

Device maker Teleflex to acquire urology company for $600M

United colonoscopy coverage change 'may cost lives,' doctors say

Roche’s Alnylam deal shows drug firms interested in heart drugs

focus

HPV vaccine, cervical cancer study delivers historic results

Russian fighter jet damages US Reaper drone with flare over Syria: Officials

What causes rare myocarditis in young men after Covid vaccines?

New Alzheimer's drugs heat up race for early detection blood tests

Readout Newsletter: Parkinson's study, Gilead, CG Oncology

Mass General, Mayo Clinic look to monetize custom

hotspot

explore

leisure time

focus